Literature DB >> 24301237

Quality of life and satisfaction of patients after full-face injections of abobotulinum toxin type A: A randomized, phase IV clinical trial.

Doris Hexsel, Cristiano Brum, Manoela D Porto, Mariana Soirefmann, Carolina Siega, Juliana Schilling-Souza, Ticiana C Rodrigues.   

Abstract

BACKGROUND: Although botulinum toxin type A (BoNT-A) has been used effectively and safely to reduce facial dynamic wrinkles, few studies assessed patients' quality of life and satisfaction after treatment.
OBJECTIVE: To assess the quality of life and satisfaction of patients treated with full-face injections of variable doses of abobotulinum toxin A (ABO).
METHODS: Ninety subjects were randomized into 3 different groups, receiving 120-165 U, 166-205 U and 206-250 U, respectively. WHOQOL- BREF and Satisfaction and Self-assessment Questionnaire (SSQ) were completed by subjects up to 6 months after treatment.
RESULTS: Most of the subjects were women (96.5%). For the physical domain in WHOQOL, a difference was observed between baseline and visit 2 (p = 0.036). There was no difference between groups for mean grades regarding amount of wrinkles, beauty, harmony and symmetry. However, there was a significant difference in the mean grades between visits. Patients' opinions also showed an improvement in their self-image up to four months after treatment, according to the self-grading.
CONCLUSION: The results presented in this study show improvements in patients' quality of life during the peak of action of BoNT-A treatment, regarding the physical aspect. In addition, patients reported good satisfaction after a full-face approach.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24301237

Source DB:  PubMed          Journal:  J Drugs Dermatol        ISSN: 1545-9616            Impact factor:   2.114


  6 in total

Review 1.  Patient Satisfaction with AbobotulinumtoxinA for Aesthetic Use in the Upper Face: A Systematic Literature Review and Post-hoc Analysis of the APPEAL Study.

Authors:  Riekie Smit; Elena Gubanova; Joely Kaufman; Marina Landau; Beatriz Molina; Bill Andriopoulos; Pascal Maisonobe; Inna Prygova; Alessio Redaelli
Journal:  J Clin Aesthet Dermatol       Date:  2021-02-01

2.  Use of AbobotulinumtoxinA for Cosmetic Treatments in the Neck, and Middle and Lower Areas of the Face: A Systematic Review.

Authors:  Hassan Galadari; Ibrahim Galadari; Riekie Smit; Inna Prygova; Alessio Redaelli
Journal:  Toxins (Basel)       Date:  2021-02-22       Impact factor: 4.546

Review 3.  Safety and Patient Satisfaction of AbobotulinumtoxinA for Aesthetic Use: A Systematic Review.

Authors:  Joel L Cohen; Nicolo Scuderi
Journal:  Aesthet Surg J       Date:  2017-05-01       Impact factor: 4.283

Review 4.  Key Parameters for the Use of AbobotulinumtoxinA in Aesthetics: Onset and Duration.

Authors:  Mark Nestor; Glynis Ablon; Andy Pickett
Journal:  Aesthet Surg J       Date:  2017-05-01       Impact factor: 4.283

5.  Efficacy and Safety of Botulinum Toxin vs. Placebo in Depression: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Huan Qian; Fangjie Shao; Cameron Lenahan; Anwen Shao; Yingjun Li
Journal:  Front Psychiatry       Date:  2020-12-04       Impact factor: 4.157

6.  The mechanisms of action and use of botulinum neurotoxin type A in aesthetics: Key Clinical Postulates II.

Authors:  Mark S Nestor; David Arnold; Daniel Fischer
Journal:  J Cosmet Dermatol       Date:  2020-09-16       Impact factor: 2.696

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.